Elevance Health, Inc. $ELV Shares Sold by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. lessened its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 3.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 149,552 shares of the company’s stock after selling 5,308 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in Elevance Health were worth $52,426,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Murphy Middleton Hinkle & Parker Inc. acquired a new stake in Elevance Health during the 4th quarter valued at approximately $5,941,000. Blume Capital Management Inc. grew its stake in Elevance Health by 236.7% during the 3rd quarter. Blume Capital Management Inc. now owns 6,145 shares of the company’s stock valued at $1,986,000 after purchasing an additional 4,320 shares in the last quarter. Victory Capital Management Inc. grew its stake in Elevance Health by 31.1% during the 3rd quarter. Victory Capital Management Inc. now owns 461,693 shares of the company’s stock valued at $149,182,000 after purchasing an additional 109,462 shares in the last quarter. Caprock Group LLC acquired a new stake in Elevance Health during the 3rd quarter valued at approximately $1,638,000. Finally, Bright Rock Capital Management LLC acquired a new stake in Elevance Health during the 4th quarter valued at approximately $7,362,000. Institutional investors and hedge funds own 89.24% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ELV. Jefferies Financial Group lowered their price objective on Elevance Health from $395.00 to $391.00 and set a “buy” rating for the company in a research note on Monday, April 20th. Wall Street Zen downgraded Elevance Health from a “buy” rating to a “hold” rating in a report on Sunday, February 8th. Truist Financial reduced their target price on Elevance Health from $390.00 to $375.00 and set a “buy” rating on the stock in a report on Monday, April 13th. Sanford C. Bernstein increased their target price on Elevance Health from $384.00 to $424.00 and gave the stock an “outperform” rating in a report on Friday, April 24th. Finally, Guggenheim increased their target price on Elevance Health from $396.00 to $399.00 and gave the stock a “buy” rating in a report on Friday, April 24th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, Elevance Health has an average rating of “Moderate Buy” and a consensus price target of $403.11.

Elevance Health Trading Up 0.4%

NYSE:ELV opened at $394.40 on Friday. The company has a market cap of $85.65 billion, a PE ratio of 16.78, a P/E/G ratio of 2.22 and a beta of 0.66. Elevance Health, Inc. has a 52 week low of $273.71 and a 52 week high of $408.00. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.70. The business’s 50 day moving average is $343.75 and its two-hundred day moving average is $338.90.

Elevance Health (NYSE:ELV) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $12.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.74 by $1.84. The business had revenue of $49.49 billion for the quarter, compared to the consensus estimate of $48.21 billion. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The business’s revenue was up 1.5% on a year-over-year basis. During the same quarter last year, the business posted $11.97 EPS. Elevance Health has set its FY 2026 guidance at 19.850- EPS. On average, analysts predict that Elevance Health, Inc. will post 26.94 EPS for the current year.

Elevance Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be issued a $1.72 dividend. The ex-dividend date of this dividend is Wednesday, June 10th. This represents a $6.88 annualized dividend and a dividend yield of 1.7%. Elevance Health’s dividend payout ratio (DPR) is 29.26%.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.